Presentation is loading. Please wait.

Presentation is loading. Please wait.

Impact of Preoperative Symptoms on Postoperative Survival in Severe Aortic Stenosis: Implications for the Timing of Surgery  Sophie Piérard, MD, Christophe.

Published byLorenz Bernt Gerhardt Modified over 5 years ago

Similar presentations

Presentation on theme: "Impact of Preoperative Symptoms on Postoperative Survival in Severe Aortic Stenosis: Implications for the Timing of Surgery  Sophie Piérard, MD, Christophe."— Presentation transcript:

1 Impact of Preoperative Symptoms on Postoperative Survival in Severe Aortic Stenosis: Implications for the Timing of Surgery  Sophie Piérard, MD, Christophe de Meester, MS, Stéphanie Seldrum, MD, Agnès Pasquet, MD, PhD, Bernhard Gerber, MD, PhD, David Vancraeynest, MD, PhD, Annie Robert, PhD, Gébrine El Khoury, MD, Philippe Noirhomme, MD, Jean-Louis Vanoverschelde, MD, PhD  The Annals of Thoracic Surgery  Volume 97, Issue 3, Pages (March 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Kaplan-Meier survival curves comparing overall postoperative survival among patients in New York Heart Association (NYHA) class I, II, III, and IV. Numbers at bottom indicate patients at risk. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Kaplan-Meier survival curves comparing overall postoperative survival among patients in New York Heart Association (NYHA) class I-II and III-IV. Numbers at bottom indicate patients at risk. The dotted line shows the survival of the age- and gender-matched Belgian population. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Kaplan-Meier survival curve showing overall postoperative survival among patients in New York Heart Association (NYHA) class I and patients who went from NYHA I to NYHA III-IV in less than 1 month. Numbers at bottom indicate patients at risk. The dotted line shows the survival of the age- and gender-matched Belgian population. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Kaplan-Meier survival curve showing overall postoperative survival in patients with no or minimal symptoms, normal preoperative left ventricular ejection fraction (LVEF ≥ 0.50) and no evidence of pulmonary hypertension (systolic pulmonary artery pressure <40 mm Hg) undergoing isolated aortic valve replacement. Numbers at bottom indicate patients at risk. Dotted line shows the survival of the age- and gender-matched Belgian population. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Impact of Preoperative Symptoms on Postoperative Survival in Severe Aortic Stenosis: Implications for the Timing of Surgery  Sophie Piérard, MD, Christophe."

Similar presentations

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,
Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.
A. Marc Gillinov, MD, Tomislav Mihaljevic, MD, Eugene H

A. Marc Gillinov, MD, Tomislav Mihaljevic, MD, Eugene H
Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,
Extending the Scope of Mitral Valve Repair in Rheumatic Disease

Extending the Scope of Mitral Valve Repair in Rheumatic Disease
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 

Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 
Pericardiectomy for Constrictive Pericarditis: 20 Years of Experience at the Montreal Heart Institute  Nicola Vistarini, MD, Christina Chen, BEng, Amine.

Pericardiectomy for Constrictive Pericarditis: 20 Years of Experience at the Montreal Heart Institute  Nicola Vistarini, MD, Christina Chen, BEng, Amine.
Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population  Christina M. Vassileva,

Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population  Christina M. Vassileva,
Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.

Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,
Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M
Lily E. Johnston, MD, MPH, Emily A. Downs, MD, Robert B

Lily E. Johnston, MD, MPH, Emily A. Downs, MD, Robert B
Aortic Valve Replacement in the Elderly: The Real Life

Aortic Valve Replacement in the Elderly: The Real Life
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Can Fontan Conversion for Patients Without Late Fontan Complications be Justified?  Akihiko Higashida, MD, Takaya Hoashi, MD, PhD, Koji Kagisaki, MD, Masatoshi.

Can Fontan Conversion for Patients Without Late Fontan Complications be Justified?  Akihiko Higashida, MD, Takaya Hoashi, MD, PhD, Koji Kagisaki, MD, Masatoshi.
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis  Christophe de Meester, MS, Agnès Pasquet,

Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis  Christophe de Meester, MS, Agnès Pasquet,
Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis  Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.

Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis  Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Aortic Valve Repair: The Functional Approach to Leaflet Prolapse and Valve-Sparing Surgery  Hugues Jeanmart, MD, Laurent de Kerchove, MD, David Glineur,

Aortic Valve Repair: The Functional Approach to Leaflet Prolapse and Valve-Sparing Surgery  Hugues Jeanmart, MD, Laurent de Kerchove, MD, David Glineur,

Similar presentations

Ads by Google